Removing a lipoprotein receptor known as SR-BI may help protect against breast cancer, as suggested by new findings presented at the American Association for Cancer Research Annual Meeting 2012 by Jefferson's Kimmel Cancer Center researchers.
In vitro and mouse studies revealed that depletion of the SR-BI resulted in a decrease in breast cancer cell growth.
SR-BI is a receptor for high-density lipoproteins (HDL) that are commonly referred to as "good cholesterol" because they help transport

Read more ...

0 comments